These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24619866)

  • 1. Adiponectin receptor expression predicts favorable prognosis in cases of hepatocellular carcinoma.
    Shin E; Yu YD; Kim DS; Won NH
    Pathol Oncol Res; 2014 Jul; 20(3):667-75. PubMed ID: 24619866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of IQGAP1/2 in Hepatocellular carcinoma and its relationship with clinical outcomes.
    Xia FD; Wang ZL; Chen HX; Huang Y; Li JD; Wang ZM; Li XY
    Asian Pac J Cancer Prev; 2014; 15(12):4951-6. PubMed ID: 24998570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adiponectin receptor expression in gastric carcinoma: implications in tumor development and progression.
    Shin E; Park DJ; Kim HH; Won NH; Choe G; Lee HS
    J Cancer Res Clin Oncol; 2013 Apr; 139(4):709-18. PubMed ID: 23358721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IMP3 combined with CD44s, a novel predictor for prognosis of patients with hepatocellular carcinoma.
    Hu S; Wu X; Zhou B; Xu Z; Qin J; Lu H; Lv L; Gao Y; Deng L; Yin J; Li G
    J Cancer Res Clin Oncol; 2014 Jun; 140(6):883-93. PubMed ID: 24647926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological and prognostic significance of Yes-associated protein expression in hepatocellular carcinoma and hepatic cholangiocarcinoma.
    Wu H; Liu Y; Jiang XW; Li WF; Guo G; Gong JP; Ding X
    Tumour Biol; 2016 Oct; 37(10):13499-13508. PubMed ID: 27465555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100A14 promotes the growth and metastasis of hepatocellular carcinoma.
    Zhao FT; Jia ZS; Yang Q; Song L; Jiang XJ
    Asian Pac J Cancer Prev; 2013; 14(6):3831-6. PubMed ID: 23886191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of matrix metalloproteinase-1/ proteinase-activated receptor-1 signaling axis in hepatocellular carcinoma.
    Liao M; Tong P; Zhao J; Zhang Y; Li Z; Wang J; Feng X; Hu M; Pan Y
    Pathol Oncol Res; 2012 Apr; 18(2):397-403. PubMed ID: 21909684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adiponectin and adiponectin receptor in relation to colorectal cancer progression.
    Byeon JS; Jeong JY; Kim MJ; Lee SM; Nam WH; Myung SJ; Kim JG; Yang SK; Kim JH; Suh DJ
    Int J Cancer; 2010 Dec; 127(12):2758-67. PubMed ID: 21351255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.
    Lei X; Li YF; Chen GD; Ou DP; Qiu XX; Zuo CH; Yang LY
    Oncotarget; 2015 Dec; 6(38):40622-41. PubMed ID: 26536663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma.
    Yang H; Xiong FX; Lin M; Yang Y; Nie X; Zhou RL
    J Cancer Res Clin Oncol; 2010 Feb; 136(2):275-81. PubMed ID: 19690886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein may be a prognostic factor in hepatocellular carcinoma with malignant portal vein invasion.
    Kim JM; Kwon CH; Joh JW; Ko JS; Park JB; Lee JH; Kim SJ; Paik SW; Park CK
    World J Surg Oncol; 2013 Apr; 11():92. PubMed ID: 23618082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Expression of Neuropilin-1 Associates with Unfavorable Clinicopathological Features in Hepatocellular Carcinoma.
    Zhang Y; Liu P; Jiang Y; Dou X; Yan J; Ma C; Fan Q; Wang W; Su F; Tang H; Su X
    Pathol Oncol Res; 2016 Apr; 22(2):367-75. PubMed ID: 26563279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy.
    Wang H; Jiang S; Zhang Y; Pan K; Xia J; Chen M
    World J Surg Oncol; 2014 Jul; 12():226. PubMed ID: 25037578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adiponectin receptor-1 expression is associated with good prognosis in gastric cancer.
    Tsukada T; Fushida S; Harada S; Terai S; Yagi Y; Kinoshita J; Oyama K; Tajima H; Fujita H; Ninomiya I; Fujimura T; Ohta T
    J Exp Clin Cancer Res; 2011 Nov; 30(1):107. PubMed ID: 22078265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of annexin A4 indicates poor prognosis and promotes tumor metastasis of hepatocellular carcinoma.
    Chen W; Chen L; Cai Z; Liang D; Zhao B; Zeng Y; Liu X; Liu J
    Tumour Biol; 2016 Jul; 37(7):9343-55. PubMed ID: 26779633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low CDX1 expression predicts a poor prognosis for hepatocellular carcinoma patients after hepatectomy.
    Zheng H; Yang Y; Wang MC; Yuan SX; Tian T; Han J; Ni JS; Wang J; Xing H; Zhou WP
    Surg Oncol; 2016 Sep; 25(3):171-7. PubMed ID: 27566019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of adiponectin receptor 1 is indicative of favorable prognosis in non-small cell lung carcinoma.
    Abdul-Ghafar J; Oh SS; Park SM; Wairagu P; Lee SN; Jeong Y; Eom M; Yong SJ; Jung SH
    Tohoku J Exp Med; 2013 Feb; 229(2):153-62. PubMed ID: 23358237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of interleukin-35 associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection.
    Fu YP; Yi Y; Cai XY; Sun J; Ni XC; He HW; Wang JX; Lu ZF; Huang JL; Cao Y; Zhou J; Fan J; Qiu SJ
    Br J Cancer; 2016 Mar; 114(7):767-76. PubMed ID: 27002937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined hepatocellular and cholangiocarcinoma originating from the same clone: a pathomolecular evidence-based study.
    Zhao Q; Yu WL; Lu XY; Dong H; Gu YJ; Sheng X; Cong WM; Wu MC
    Chin J Cancer; 2016 Aug; 35(1):82. PubMed ID: 27552844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low expression of organic anion-transporting polypeptide 1B3 predicts a poor prognosis in hepatocellular carcinoma.
    Chen S; Li K; Jiang J; Wang X; Chai Y; Zhang C; Deng Q; Shuai L; Feng K; Ma K; Zhang L
    World J Surg Oncol; 2020 Jun; 18(1):127. PubMed ID: 32534581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.